• Hanmi Pharmaceutical will attend Mirae Asset Securities' non-deal roadshow in Seoul on Nov. 2, 2026.
• One-on-one, in-person meetings with domestic institutional investors will begin at 10 a.m.
• Discussions will cover third-quarter 2026 business performance, followed by Q&A.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanmi Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261030800861), on October 30, 2026, and is solely responsible for the information contained therein.